SKI Market

A+| A| A-|

Indian Indices

Sensex

75,527.95 1,695.40
( 2.30%)

Global Indices

Nasdaq

51,233.54 363.79
(0.72%)

Dow Jones

7,453.14 37.84
(0.51%)

Hang Seng

66,063.56 1,846.29
(2.88%)

Nikkei 225

10,460.24 156.36
(1.52%)

Forex

USD-INR

95.49 0.16
(0.17%)

EUR-INR

110.25 0.17
(0.15%)

GBP-INR

127.74 0.15
(0.12%)

JPY-INR

0.60 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Vilin Bio Med Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE Code

ISIN Demat

Book Value()

78871

INE0L4V01013

18.6032787

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

VILINBIO

37.3

71.68

EPS(TTM)

Face Value()

Div & Yield %

1.26

Back

n2n technologies ltd

Manaksia consolidated net profit rises 13.75% in the December 2025 quarter

Jan 31,2026

Net profit of Manaksia rose 13.75% to Rs 14.56 crore in the quarter ended December 2025 as against Rs 12.80 crore during the previous quarter ended December 2024. Sales declined 2.06% to Rs 184.02 crore in the quarter ended December 2025 as against Rs 187.90 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	184.02	187.90	-2
OPM %	3.74	8.87	-
PBDT	22.32	20.39	9
PBT	20.73	19.04	9
NP	14.56	12.80	14

75,527.95 1,695.40 ( 2.30%)

51,233.54 363.79 (0.72%)

7,453.14 37.84 (0.51%)

66,063.56 1,846.29 (2.88%)

10,460.24 156.36 (1.52%)

95.49 0.16 (0.17%)

110.25 0.17 (0.15%)

127.74 0.15 (0.12%)

0.60 0.00 (0.21%)